You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: September 19, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Exemestane

A generic version of EXEMESTANE was approved as exemestane by HIKMA on April 1st, 2011.

  Start Trial

Drug patent expirations by year for EXEMESTANE
Drug Prices for EXEMESTANE

See drug prices for EXEMESTANE

Recent Clinical Trials for EXEMESTANE

Identify potential brand extensions & 505(b)(2) entrants

First Affiliated Hospital, Sun Yat-Sen UniversityPhase 2
Fudan UniversityPhase 2
Istituto Di Ricerche Farmacologiche Mario NegriPhase 3

See all EXEMESTANE clinical trials

Pharmacology for EXEMESTANE
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors

US Patents and Regulatory Information for EXEMESTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen EXEMESTANE exemestane TABLET;ORAL 200898-001 Jul 28, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan EXEMESTANE exemestane TABLET;ORAL 203315-001 Mar 10, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Cipla EXEMESTANE exemestane TABLET;ORAL 210323-001 Apr 27, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Qilu EXEMESTANE exemestane TABLET;ORAL 213547-001 Apr 13, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.